ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $584,126 | +112883.8% | 6,238 | +7.7% | 0.04% | +19.4% |
| Q2 2023 | $517 | -15.0% | 5,790 | +2.0% | 0.03% | -16.2% |
| Q1 2023 | $608 | +5.7% | 5,674 | +20.5% | 0.04% | +5.7% |
| Q4 2022 | $575 | -100.0% | 4,710 | -61.9% | 0.04% | -54.5% |
| Q1 2022 | $1,450,000 | -16.9% | 12,351 | -4.8% | 0.08% | -10.5% |
| Q4 2021 | $1,745,000 | -55.3% | 12,973 | -47.1% | 0.09% | -58.0% |
| Q3 2021 | $3,908,000 | +15.7% | 24,518 | -4.5% | 0.20% | +13.9% |
| Q2 2021 | $3,377,000 | +4.6% | 25,673 | +2.5% | 0.18% | -7.2% |
| Q1 2021 | $3,228,000 | – | 25,047 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |